We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+7.1%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.69B
AUM Growth
+$214M
Cap. Flow
+$72.4M
Cap. Flow %
2.69%
Top 10 Hldgs %
36.8%
Holding
3,484
New
256
Increased
1,490
Reduced
872
Closed
231
Avg Time Held Equity + Options
2.8 years
Top 10 Avg Time Held Equity + Options
2.2 years
Top 20 Avg Time Held Equity + Options
2.1 years
Avg Time Held Equity only
2.8 years
Top 10 Avg Time Held Equity only
2.2 years
Top 20 Avg Time Held Equity only
2.1 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 51.24%
2 Technology 16.87%
3 Financials 7.26%
4 Healthcare 6.41%
5 Consumer Discretionary 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MVST icon
3201
Microvast
MVST
$210M
$0 ﹤0.01%
30
-500
-94% -$3.95K
2021 Q1
3 quarters
MXI icon
3202
iShares Global Materials ETF
MXI
$433M
$0 ﹤0.01%
5
– –
2021 Q2
2 quarters
MYE icon
3203
Myers Industries
MYE
$1.15B
$0 ﹤0.01%
5
-629
-99% -$12.7K
2021 Q1
3 quarters
MYPS icon
3204
PLAYSTUDIOS Inc
MYPS
$51.1M
– –
-90
Closed -$4K –
MYPSW icon
3205
DELISTED
PLAYSTUDIOS Inc Warrant
MYPSW
– –
-298
Closed – –
NCMI icon
3206
National CineMedia
NCMI
$210M
– –
-42
Closed -$1K –
NFE icon
3207
New Fortress Energy
NFE
$24.4M
– –
0
– –
2021 Q4
0 quarters
NGNE icon
3208
Neurogene
NGNE
$484M
– –
-3
Closed – –
NOMD icon
3209
Nomad Foods
NOMD
$1.61B
– –
-468
Closed -$13K –
NOVT icon
3210
Novanta
NOVT
$5.15B
$0 ﹤0.01%
2
+1
+100% +$167
2021 Q3
1 quarter
NRC icon
3211
NRC Health Common Stock
NRC
$468M
$0 ﹤0.01%
+11
New +$478
2021 Q4
0 quarters
NRIX icon
3212
Nurix Therapeutics
NRIX
$2.72B
$0 ﹤0.01%
+9
New +$273
2021 Q4
0 quarters
NTST icon
3213
NETSTREIT Corp
NTST
$1.77B
$0 ﹤0.01%
9
-157
-95% -$3.64K
2021 Q3
1 quarter
IMDX icon
3214
Insight Molecular Diagnostics
IMDX
$94.2M
– –
-11
Closed -$1K –
OGI icon
3215
Organigram Holdings
OGI
$134M
$0 ﹤0.01%
33
– –
2019 Q3
9 quarters
OM icon
3216
Outset Medical
OM
$75.2M
– –
-6
Closed -$5K –
OPI
3217
DELISTED
Office Properties Income Trust
OPI
– –
-6
Closed – –
OPRX icon
3218
OptimizeRx
OPRX
$163M
– –
-65
Closed -$6K –
OSPN icon
3219
OneSpan
OSPN
$653M
$0 ﹤0.01%
1
-229
-100% -$4.27K
2021 Q2
2 quarters
OSUR icon
3220
OraSure Technologies
OSUR
$261M
$0 ﹤0.01%
22
– –
2019 Q4
8 quarters
PACK icon
3221
Ranpak Holdings
PACK
$295M
$0 ﹤0.01%
+7
New +$247
2021 Q4
0 quarters
PAGS icon
3222
PagSeguro Digital
PAGS
$3.06B
– –
-782
Closed -$40K –
PAHC icon
3223
Phibro Animal Health
PAHC
$1.59B
$0 ﹤0.01%
10
-15
-60% -$320
2021 Q2
2 quarters
PATK icon
3224
Patrick Industries
PATK
$2.17B
– –
-9
Closed – –
PAVM icon
3225
PAVmed
PAVM
$18.4M
– –
-1
Closed -$2.17K –

Similar funds

Parallel Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Parallel Advisors held 3,484 positions worth $2.69B, up 8.6% from $2.48B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors's Q4 2021 filing shows 256 new, 1,490 increased, 872 reduced and 231 closed positions. Its largest new stake was Payoneer: 1,784,455 shares worth $13.1M. The largest sale was iShares US Treasury Bond ETF, an estimated $17.7M.

By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 52% a quarter earlier, followed by Technology and Financials.

  • Parallel Advisors's largest Q4 2021 buy was Payoneer: 1,784,455 shares worth $13.1M.
  • Parallel Advisors added most to iShares Core MSCI EAFE ETF in Q4 2021, an estimated $29.6M increase.
  • Parallel Advisors's biggest Q4 2021 reduction was iShares US Treasury Bond ETF, cutting an estimated $17.7M.
  • Parallel Advisors fully exited FTAC Olympus Acquisition Corp. Class A Ordinary Shares in Q4 2021, selling an estimated $15.5M.
  • Parallel Advisors's ten largest holdings make up 37% of its $2.69B portfolio in Q4 2021.
  • Parallel Advisors opened 256 new positions and closed 231 in Q4 2021.
  • Parallel Advisors's portfolio value rose 8.6% quarter-over-quarter to $2.69B.

Based on Parallel Advisors's 13F filing for Q4 2021, filed 20 Jan 2022.